My Trefis

Join Trefis today!

Register to create your own "My Trefis" of stocks, news, and people that interest you.

Example question: Bloomberg reported that supply constraints are leading to iPhone shortages. Do Trefis analysts see a meaningful impact on AAPL?
Example comment: Competition will squeeze AMZN's operating margins from 4% to 2% meaning a 10% hit to the stock according to Trefis.
Name (Required)
Email (Required, but never displayed)
* Companies:
Medtronic Logo
  • commented 5 months ago
  • tags: BSX MDT
  • Given the increasing incidence of obesity and diabetes, I think the diabetes segment is underappreciated. At the moment, they are the only ones with a pump which suspends in dangerous hypoglycemia, and it's competitors (the animus and omni pod pumps) don't come close in terms of software. Every endocrinologist I know favors Medtronic software and customer service, and seeing as how pump therapy is gaining wider acceptance in type 2 diabetic treatment (it's not just type 1 anymore), I think the diabetes segment is going to be huge in the next 3-5 years. If they successfully develop their closed loop technology algorithms, ie a true 'artificial pancreas,' it is game over for everyone else in the pump industry. [ less... ]
    Given the increasing incidence of obesity and diabetes, I think the diabetes segment is underappreciated. At the moment, they are the only ones with a pump which suspends in dangerous hypoglycemia, and it's competitors (the animus and omni pod pumps) don't come close in terms of software. Every endocrinologist I know favors Medtronic software and customer service, and seeing as how pump therapy is gaining wider acceptance in type 2 diabetic treatment (it's not just type 1 anymore), I think the diabetes segment is going to be huge in the next 3-5 years. If they successfully develop their closed loop technology algorithms, ie a true 'artificial pancreas,' it is game over for everyone else in the pump industry.
    Name (Required)
    Email (Required, but never displayed)

    DISCLAIMER

    By using the Site, you agree to be bound by our Terms of Use. Financial market data powered by Quotemedia.com. Consensus EPS estimates are from QuoteMedia and are updated every weekday. All rights reserved.

    Terms of Use

    NYSE/AMEX data delayed 20 minutes. NASDAQ and other data delayed 15 minutes unless indicated.